Abstract
Due to the current demand for donor hearts, the limits of acceptable organs are increasingly being pushed. Previous literature has shown that prolonged ischaemic time in transport remains a key limitation, with excess morbidity such as early primary graft dysfunction requiring veno-arterial extracorporeal membrane oxygenation (VA-ECMO) (rates of up to 30% have been reported). This study highlighted outcomes from the first 10 patients who received a donor heart retrieved on the XVIVO hypothermic perfusion organ care device at St Vincent’s Hospital, Sydney.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
